- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05033262
Our Care Wishes - Dementia
June 21, 2023 updated by: University of Pennsylvania
Adaptation of the OurCareWishes.Org ACP Platform for Persons With Dementia in NHs and Their Caregivers
This Our Care Wishes- Dementia pilot study is adapting an existing successful online advance care planning platform to the specific needs of persons living with dementia and shared decision-makers (SDMs) and testing the usability and acceptability among nursing home residents and SDMs.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104-4217
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Eligible PLWD will be receiving short-or long-term care at a participating NH, have documented moderate to severe cognitive impairment as measured by the Cognitive Function Scale included in the Minimum Data Set 3.0, 65 and have an identified SDM.
Exclusion Criteria:
- Participants are not eligible discharged from participating NHs, or do not have access to a telephone or video chat.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Participants who are allocated to the control arm will complete baseline measures and then receive usual advanced care planning care and discussions with the nursing facility staff.
Control arm participants will not review the Our Memory Care Wishes website.
Participants will complete follow up measures one week after the baseline interview.
|
|
|
Experimental: Intervention
Participants allocated to the intervention group will complete baseline measures.
Then, the participant will review the Our Memory Care Wishes website and enter advanced care planning decisions and preferences into the website.
Participants will complete follow up measures one week after the baseline interview.
Participants receiving the intervention will complete additional follow up measures which include surveys measuring the ease of use of the website.
|
Our Memory Care Wishes is a web-based advance care planning platform designed for persons living with dementia in nursing homes to discuss and document healthcare and daily life preferences with the help of shared decision-makers.
Penn researchers meet via Zoom with PLWD and their SDMS and nursing home staff to facilitate website completion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adapted Decision Making Confidence Scale
Time Frame: Baseline
|
Items from the Surrogate Decision-Making Confidence Scale and 9-item ACP Engagement Survey were used and adapted to capture the confidence in advanced care planning decision-making from both persons living with dementia and their shared decision-maker' points of view.
The scale utilizes a Likert scale with values ranging from 1 (not confident at all) to 5 (very confident).
|
Baseline
|
|
Post Adapted Decision Making Confidence Scale
Time Frame: 1 week
|
Items from the Surrogate Decision-Making Confidence Scale and 9-item ACP Engagement Survey were used and adapted to capture the confidence in advanced care planning decision-making from both persons living with dementia and their shared decision-maker' points of view.
The scale utilizes a Likert scale with values ranging from 1 (not confident at all) to 5 (very confident).
This is the second time point the measure was collected.
|
1 week
|
|
Website Ease of Use
Time Frame: 1 week
|
This scale measures the ease of use of the website.
This scale uses a Likert scale from 0 (very hard) to 10 (very easy).
These data were collected from PLWDs and SDMs in the intervention group.
|
1 week
|
|
Rate of ACP Website Completion - Time
Time Frame: 1 week
|
This tool measured total time spent by participants on the advance care planning website.
Total time in minutes spent on the website were collected.
Because SDMs navigated the website with the PLWD alongside them, this measure was only used to SDMs in the intervention group.
|
1 week
|
|
Rate of ACP Website Completion - Questions Completed
Time Frame: 1 week
|
This tool measured what percentage of the website was completed by participants.
Because SDMs navigated the website with the PLWD alongside them, this measure was only associated with SDMs in the intervention group.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
COVID-19 Impact Questionnaire
Time Frame: 1 week
|
This scale measures how participants' advance care planning decisions were impacted by the COVID-19 pandemic.
Participants can choose whether or not the COVID-19 pandemic affected their healthcare preferences, specifically if participants prefer to receive care via a ventilator and if participants prefer to receive treatment in nursing facility over visiting the hospital.
|
1 week
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
COVID-19 Impact Questionnaire
Time Frame: 1 week
|
Participants were asked if their healthcare preferences changed due to the COVID-19 pandemic. Items included:
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2020
Primary Completion (Actual)
September 8, 2021
Study Completion (Actual)
September 8, 2021
Study Registration Dates
First Submitted
August 18, 2021
First Submitted That Met QC Criteria
August 27, 2021
First Posted (Actual)
September 2, 2021
Study Record Updates
Last Update Posted (Actual)
June 22, 2023
Last Update Submitted That Met QC Criteria
June 21, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 834878
- P30AG064105-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongNot yet recruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on Our Memory Care Wishes
-
University of PennsylvaniaCompletedHospitalismUnited States
-
Milton S. Hershey Medical CenterNational Institute of Nursing Research (NINR); Brigham and Women's HospitalCompletedHeart Failure | Neoplasms | Lung Diseases | Kidney DiseasesUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedDepression | AnxietyUnited States
-
Milton S. Hershey Medical CenterAmerican Cancer Society, Inc.Completed
-
Johns Hopkins UniversityNational Institute on Aging (NIA); MedStar Health; Johns Hopkins Community PhysiciansCompleted
-
Pastoral Activities and Service for AIDS Dar-Es-Salaam...King's College London; University of Cape TownUnknown
-
Sodra Alvsborgs HospitalNot yet recruiting
-
Thomas Jefferson UniversityCompletedDiabetes | Mild Cognitive ImpairmentUnited States
-
Cooperativa de Ensino Superior, Politécnico e UniversitárioCompleted
-
Centre Oscar LambretSCALab UMR CNRS 9193 Université de LilleTerminatedKidney Cancer | Colorectal Cancer | Prostate Cancer | Bladder Cancer | Advanced SarcomaFrance